Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Steve Fancy who wrote (3652)	1/23/1998 10:04:00 AM
From: Lenny Ehn	Read Replies (1) of 6136

To thread, Last time I checked, First Call earnings estimates for FY98 were $1.38. If we assign a P/E range of 25-30, which is high in current stock market atmosphere, the 12-month price target would appear to be in the $35-40 range. I am long AGPH and wondering about whether to continue holding it. Can anyone give me a reason why the price is likely to go higher than the range I've indicated above? Has all (or most) of the good news already been discounted by the market at current price levels? All statistically backed opinions welcomed! Len

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next